BillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™, the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy test, Northstar, that combines treatment selection with monitoring. To date, over 500,000 patients have benefited from our innovative and precise diagnostic tests, and our Annual Recurring Revenue (ARR) has grown from $0 to $125 million in the last ~4 years.
BillionToOne has successfully raised close to $400 million in funding, with a notable $130 million Series D round completed in June 2024, resulting in a company valuation of over $1 billion. This funding has come from prestigious global institutional investors, including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest. BillionToOne has recently been recognized by Forbes as one of America's Best Startup Employers for 2024, highlighting the company's exceptional work environment and commitment to innovation.
Our team has grown significantly and we now proudly employ over 400 highly skilled individuals. Despite substantial growth, we have successfully maintained the unique culture that has defined BillionToOne from inception, continuing to cultivate a team that is not only diverse and passionate but also innovative. Headquartered in Menlo Park, California, with an additional facility in Union City, California, BillionToOne remains at the forefront of significant advances in molecular diagnostics, evidenced by the recent announcement of clinical outcomes data for its Unity Fetal Risk Screen and new advancements in cancer diagnostics. For more detailed information about BillionToOne and its groundbreaking work, please visit our website at www.billiontoone.com.
The Senior Prenatal Specialist is a seasoned prenatal sales executive, who will bring the first and only single-gene NIPT supported carrier and aneuploidy screen to OBGYN clinics & MFM practices. You will provide clinical information to external accounts throughout your territory and internal teams. You will have significant influence over how the test is communicated to physicians and patients, and how it should evolve to better serve market needs. This is a remote position and reports to a Regional Manager - Prenatal.
Responsibilities:
- Create and implement a strategic, data-driven business plan to build out the territory and grow revenue quickly
- Drive market adoption, sales, and territory growth through direct sales to individual OBGYNs, MFMs, and Genetic Counselors.
- Prospect and cultivate new business, and actively maintain existing relationships.
Requirements:
- Minimum three (3) years of Women's Health sales experience at a genetics or molecular diagnostics company in this territory; must have existing relationships with OBGYNs, MFMs, GCs, etc. and convertible business
- Will consider Women’s Health medical device sales experience if all other requirements are met and there is strong convertible business
- Proven track record of sales success (eg. National award winning - President Club or equivalent required); if company does not have national sales awards, must have comparable performance (ie. top 10% of salesforce nationally; strong demonstrated growth in sales volume and territory)
- Solid negotiation skills, understanding of buyer/decision maker types, exhibit effective selling, listening, presentation skills, and ability to assess and respond to customer needs
- Effective time management skills required with a demonstrated ability to assess and prioritize opportunity required
- Must act with a sense of urgency, with a focus on closing and pulling through business
- Ability to assess the needs of medical professionals and staff members with a focus on consultative sales, coordination of logistics, and problem solving
- Strong desire to work in a startup environment and must work independently with an internal drive to be successful
Nice-to-Haves:
- Experience in a start-up environment
- Clinical laboratory experience
- Prior field training experience
Benefits And Perks:
- Working with a team of ‘rockstars’ who bring out the best in everyone
- Open, transparent culture that includes weekly Town Hall meetings
- The ability to indirectly or directly change the lives of hundreds of thousand patients
- Multiple medical benefit options; employee premiums paid 100% of select plans, dependents covered at 80%
- Extremely generous Family Bonding Leave for new parents (16 weeks, paid at 100%)
- Retirement savings program including a 4% Company match
- Free daily on-site lunches provided from top eateries
- Latest and greatest hardware (laptop, lab equipment, facilities)
- A variety of perks on campus (state of the art gym, restaurant)
- Free on-site EV charging (compatible with all EVs, including Tesla)
At BillionToOne, we are proud to offer a combination of a (1) base pay (2) generous equity options offering, on top of (3) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave etc.
This position offers an annual compensation package, which includes a base pay of $140,000 in combination with uncapped quarterly sales commissions.
BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
What We Do
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending molecular counter platform is the only technology platform that can accurately count the DNA molecules at the single-count level.
